Ergomed competitors

Ergomed's competitors include Amphastar Pharmaceuticals, SuperX, AB Science and Evgen Pharma
Add company...
Ergomed
Ergomed PLC is a United Kingdom-based provider of drug development services to the pharmaceutical industry.
Amphastar Pharmaceuticals
A specialty pharmaceutical company engaged in the development, manufacturing and marketing of generic and proprietary injectable and inhalation products.
SuperX
SuperX is a virtual biopharmaceutical company developing products to deliver anticoagulation without bleeding.
AB Science
AB Science S.A., a pharmaceutical company, engages in the discovery, development, and commercialization of protein kinase inhibitors for use in human and veterinary medicines.
Evgen Pharma
Evgen Pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions and the lead product is Sulforadex.
Founding Date
Founding Date
N/A
Founding Date
1996
Founding Date
2016
Founding Date
2001
Founding Date
2007
Type
Type
Public
Type
Public
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Guildford, GB HQ
Locations
Rancho Cucamonga, US HQ
Locations
Cambridge, GB HQ
Locations
Paris, FR HQ
Chatham, US
Locations
Liverpool, GB HQ
London, GB
Employees
Employees
150
Employees
1,541
Employees
12
Employees
11714% decrease
Employees
2
Valuation ($)
Valuation ($)
113 m
Valuation ($)
834.5 m
Valuation ($)
N/A
Valuation ($)
431.7 m
Valuation ($)
16.8 m
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
118
Twitter followers
N/A
Twitter followers
141

Financial

Revenue (est.)
Revenue (est.)
£47.6m (FY, 2017)
Revenue (est.)
$240.2m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
£33m (FY, 2017)
Cost of goods
$149.4m (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
£14.6m (FY, 2017)
Gross profit
$90.8m (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Net income
Net income
(£4.5m) (FY, 2017)
Net income
$4.5m (FY, 2017)
Net income
N/A
Net income
N/A
Net income
(£3.1m) (FY, 2017)
For sources of this data, please see the company profileDownload Excel

View company profiles

Amphastar Pharmaceuticals
HQ
Rancho Cucamonga, US
Employees
1,541

A specialty pharmaceutical company engaged in the development, manufacturing and marketing of generic and proprietary injectable and inhalation products.

View company
SuperX
HQ
Cambridge, GB
Employees
12

SuperX is a virtual biopharmaceutical company developing products to deliver anticoagulation without bleeding.

View company
AB Science
HQ
Paris, FR
Employees
117↓ 14% decrease

AB Science S.A., a pharmaceutical company, engages in the discovery, development, and commercialization of protein kinase inhibitors for use in human and veterinary medicines.

View company
Evgen Pharma
HQ
Liverpool, GB
Employees
2

Evgen Pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions and the lead product is Sulforadex.

View company